Leukocyte News and Research

RSS

Individuals with major depression have an exaggerated inflammatory response to psychological stress

Individuals with major depression have an exaggerated inflammatory response to psychological stress compared to those who do not suffer from depression, according to a study by researchers at Emory University School of Medicine.

4 Sep 2006

New method of gene therapy alters immune cells for treatment of advanced melanoma

A team of researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, has demonstrated sustained regression of advanced melanoma in a study of 17 patients by genetically engineering patients' own white blood cells to recognize and attack cancer cells.

4 Sep 2006

New cell-based targets for treating autoimmune inflammatory diseases

Patients with systemic autoimmune diseases such as lupus and rheumatoid arthritis (RA) often suffer loss of kidney function.

31 Aug 2006

FDA approves Plavix for STEMI heart attacks

The Food and Drug Administration (FDA) today approved the use of Plavix (clopidogrel bisulfate) for patients who have had a type of heart attack called acute ST-segment elevation myocardial infarction (STEMI), who are not going to have coronary artery repair (angioplasty).

17 Aug 2006

Chemotherapy and breast cancer - side effects underestimated

Researchers believe that the side effects of chemotherapy treatment for breast cancer are probably higher than thought.

16 Aug 2006

Discovery of mechanism that may explain post-transplant lymphoproliferative disorder

A serious form of cancer that occurs in some transplant patients may arise because cells that normally serve as scouts for the immune system become weakened, a new study suggests.

8 Aug 2006

Turning the immune system against cancer

Medicine can now prevent a host of diseases with a mere shot of vaccine. Polio and smallpox are almost non-existent, and mumps and chicken pox are rarely seen nowadays.

4 Aug 2006

FDA expands use of Oncaspar to include treating children and adults with newly diagnosed acute lymphoblastic leukemia

The U.S. Food and Drug Administration (FDA) has expanded the approved use of Oncaspar to include treating children and adults with newly diagnosed acute lymphoblastic leukemia (ALL) as part of a multiple drug chemotherapy regimen.

25 Jul 2006

Gleevec may cause heart problems

Gleevec, the wildly successful poster-child of a new generation of cancer drugs aimed at specific targets in the cancer cell, can be dangerous to the heart.

24 Jul 2006

Research offers new hope in helping elderly fight infections

Thousands of infections could be prevented each year in older people and hospital stays reduced following findings from two studies which show that imbalances in the immune systems of people aged over 65 make them more prone to illnesses like flu or bacterial infections as a result of cuts and falls.

21 Jul 2006

Researchers isolate rare cancer stem cells that cause leukemia

Researchers at Dana-Farber Cancer Institute and Children's Hospital Boston and their colleagues have isolated rare cancer stem cells that cause leukemia in a mouse model of the human disease.

18 Jul 2006

FDA approval for Gemzar for ovarian cancer

Eli Lilly and Company announced that the United States Food and Drug Administration (FDA) has approved Gemzar (gemcitabine HCl) for use in the treatment of women living with recurrent ovarian cancer.

18 Jul 2006

Eicosanoids and inflammatory response

Revolutionary new results concerning substances that play major roles in the inflammatory response have been published in the American scientific journal PNAS in two articles from Karolinska Institutet.

18 Jul 2006

Researchers discover two-way communication and stimulation between blood stem cells and T cells

When a transplant patient suffers complications such as graft rejection or graft-versus-host disease, physicians attempt to stop the body's immune response by targeting a patient's T cells.

13 Jul 2006

Natural mechanism protecting tissue allografts from rejection

A molecule expressed during pregnancy seems to turn down the immune system, making it more tolerant of welcome visitors such as a fetus or maybe a transplanted heart, researchers say.

10 Jul 2006

Dog DNA provides clues to combating diseases such as diabetes and multiple sclerosis in humans

Melbourne researchers are examining the DNA of dogs in a research project aiming at determining the genetic causes of common pet diseases - and to provide a model for combating diseases such as diabetes and multiple sclerosis in humans.

5 Jul 2006

Scientists find a cytokine against auto-immune hepatitis

There are about 400 million patients of hepatitis in the world. Some of them are suffering from autoimmune hepatitis, a disease in which the body's immune system attacks liver cells.

5 Jul 2006

FDA grants accelerated approval for Sprycel (dasatinib)

FDA grants accelerated approval for Sprycel (dasatinib), a new oral treatment for patients with chronic myeloid leukemia (CML),

29 Jun 2006

Central nervous system can sometimes send out signals that invite hostile immune system attacks

It may sound like a case of blame the victim, but researchers at Washington University School of Medicine in St. Louis have shown that cells in the central nervous system can sometimes send out signals that invite hostile immune system attacks.

18 Jun 2006

First drug treatment for late-stage cervical cancer approved

FDA has approved a combination of Hycamtin (topotecan hydrochloride) and cisplatin for use as the first drug treatment for women with late-stage cancer of the cervix.

18 Jun 2006

Leukocyte News and Research

Individuals with major depression have an exaggerated inflammatory response to psychological stress

New method of gene therapy alters immune cells for treatment of advanced melanoma

New cell-based targets for treating autoimmune inflammatory diseases

FDA approves Plavix for STEMI heart attacks

Chemotherapy and breast cancer - side effects underestimated

Discovery of mechanism that may explain post-transplant lymphoproliferative disorder

Turning the immune system against cancer

FDA expands use of Oncaspar to include treating children and adults with newly diagnosed acute lymphoblastic leukemia

Gleevec may cause heart problems

Research offers new hope in helping elderly fight infections

Researchers isolate rare cancer stem cells that cause leukemia

FDA approval for Gemzar for ovarian cancer

Eicosanoids and inflammatory response

Researchers discover two-way communication and stimulation between blood stem cells and T cells

Natural mechanism protecting tissue allografts from rejection

Dog DNA provides clues to combating diseases such as diabetes and multiple sclerosis in humans

Scientists find a cytokine against auto-immune hepatitis

FDA grants accelerated approval for Sprycel (dasatinib)

Central nervous system can sometimes send out signals that invite hostile immune system attacks

First drug treatment for late-stage cervical cancer approved

Immunology eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News